Method for building N-glycosylation receptor protein models in Escherichia coli by aid of skeleton proteins Fn3 (fibronectin type III domain)
A skeleton protein, Escherichia coli technology, applied in the biological field, can solve the problems of increased difficulty in recombinant oligosaccharide analysis, low efficiency of recombinant protein, increased difficulty in separation and purification of glycoproteins, etc., and achieves high-efficiency in vitro glycosylation modification and improved solubility. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] 1. In this example, the human framework protein fibronectin type III domain (Fn3) protein is used as the model gene (EMBL accession number AJ320527). At the 3' end of the gene, 6 histidine residues are introduced, and at the 3' end, a base sequence encoding the glycosylation site DQNAT is introduced. For the structure of the fusion gene, see figure 1 . The gene was constructed into pIG6H by gene recombination, see the vector structure figure 2 .
[0025] 2. After the human fibronectin type III domain recombinant gene Fn3-Gly expression cassette sequence shown in the sequence table was synthesized (Nanjing GenScript Biotechnology Co., Ltd.), it was constructed on the Escherichia coli expression vector pIG6H with EcoRV and HindIII, The recombinant vector pIG6H-Fn3-Gly was obtained.
[0026] 3. the expression vector constructed and pACYCpgl electric shock transformation CLM37 escherichia coli bacterial strain, then transformants were inoculated to the LB solid medium (...
Embodiment 2
[0033] 1. In this example, the human framework protein fibronectin type III domain (Fn3) protein is used as the model gene (EMBL accession number AJ320527). At the 3' end of the gene, 6 histidine residues are introduced, and at the 3' end, a base sequence encoding the glycosylation site DQNAT is introduced. For the structure of the fusion gene, see figure 1 . The gene was constructed into pIG6H by gene recombination, see the vector structure figure 2 .
[0034] 2. After the human fibronectin type III domain recombinant gene Fn3-Gly expression cassette sequence shown in the sequence table was synthesized (Nanjing GenScript Biotechnology Co., Ltd.), it was constructed on the Escherichia coli expression vector pIG6H with EcoRV and HindIII, The recombinant vector pIG6H-Fn3-Gly was obtained.
[0035] 3. the expression vector constructed and pACYCpgl electric shock transformation CLM37 escherichia coli bacterial strain, then transformants were inoculated to the LB solid medium (...
Embodiment 3
[0042] 1. In this example, the human framework protein fibronectin type III domain (Fn3) protein is used as the model gene (EMBL accession number AJ320527). At the 3' end of the gene, 6 histidine residues are introduced, and at the 3' end, a base sequence encoding the glycosylation site DQNAT is introduced. For the structure of the fusion gene, see figure 1 . The gene was constructed into pIG6H by gene recombination, see the vector structure figure 2 .
[0043] 2. After the human fibronectin type III domain recombinant gene Fn3-Gly expression cassette sequence shown in the sequence table was synthesized (Nanjing GenScript Biotechnology Co., Ltd.), it was constructed on the Escherichia coli expression vector pIG6H with EcoRV and HindIII, The recombinant vector pIG6H-Fn3-Gly was obtained.
[0044] 3. the expression vector constructed and pACYCpgl electric shock transformation CLM37 escherichia coli bacterial strain, then transformants were inoculated to the LB solid medium (...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com